Rajendra Nath
Overview
Explore the profile of Rajendra Nath including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
114
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kartik S, Pal R, Chaudhary M, Nath R, Kumar M
Ann Neurosci
. 2025 Jan;
31(4):265-276.
PMID: 39840143
Background: Parkinson's disease (PD) is characterized by dopaminergic (DA) neuron loss, Lewy body build-up, and motor dysfunction. One of the primary pathogenic mechanisms of PD development is autophagy dysfunction and...
2.
Tiwari P, Chaudhary M, Pal R, Nath R
Ann Neurosci
. 2024 Aug;
31(3):186-203.
PMID: 39156628
Background: Parkinson's disease (PD) is typified by inflammation of dopaminergic neurons leading to the release of various inflammatory mediators. These mediators activate the transcription factor NF-κB, which in turn activates...
3.
Hasan S, Verma A, Haque S, Asif F, Nath R, Kant S, et al.
Perspect Clin Res
. 2024 Aug;
15(3):141-146.
PMID: 39140017
Aim: The aim of this study was to monitor prescription patterns, clinical outcomes, and adverse drug reactions (ADR) among patients of various interstitial lung diseases (ILDs). Materials And Methods: This...
4.
Tiwari P, Pal R, Chaudhary M, Nath R
Drug Dev Res
. 2023 Sep;
84(8):1652-1663.
PMID: 37712494
By harnessing artificial intelligence (AI) algorithms and machine learning techniques, the entire drug discovery process stands to undergo a profound transformation, offering a myriad of advantages. Foremost among these is...
5.
Kumar P, Singh A, Kumar A, Kumar R, Pal R, Sachan A, et al.
Biomedicines
. 2023 May;
11(5).
PMID: 37239093
The most frequent neurodegenerative illness among senior people and the main cause of dementia is Alzheimer's disease. The present dementia medications available only help with the symptoms of cognitive deficits...
6.
Agarwal A, Ansari A, Nath R, Chak R, Singh R, Khanna R, et al.
J Dent Anesth Pain Med
. 2023 Apr;
23(2):69-81.
PMID: 37034838
Background: In order to assess the effectiveness of various analgesio-sedative combinations for pain relief and sedation in pediatric dental patients, a thorough evaluation of clinical studies and patient outcomes is...
7.
Kartik S, Pal R, Chaudhary M, Tiwari P, Nath R, Kumar M
Fundam Clin Pharmacol
. 2023 Feb;
37(4):794-806.
PMID: 36807936
Parkinson's disease (PD) is a neuromuscular ailment that affects people in their later years and causes both motor and non-motor deficits. Receptor-interacting protein-1 (RIP-1) is a critical participant in necroptotic...
8.
Kartik S, Pal R, Chaudhary M, Nath R, Kumar M, Binwal M, et al.
Inflammopharmacology
. 2023 Jan;
31(2):927-941.
PMID: 36715843
Parkinson's disease (PD) is a neuro-motor ailment that strikes adults in their older life and results in both motor and non-motor impairments. In neuronal and glial cells, PD has recently...
9.
Tiwari P, Chaudhary M, Pal R, Nath R
Fundam Clin Pharmacol
. 2022 Jul;
36(6):944-955.
PMID: 35853641
Nitric oxide (NO), generated by nitric oxide synthase enzymes (NOS), has an important role in maintaining synapse plasticity, neuro-modulation, and other physiological functions in the brain. NO thus generated also...
10.
Akhtar J, Singh S, Verma A, Pal R, Nath R
Indian J Tuberc
. 2022 Jun;
69(3):341-346.
PMID: 35760484
Background: Anti-TB drugs are most common cause of idiosyncratic hepatotoxicity worldwide. Reactive metabolite formed during drug metabolism has been involved in a clinical toxicity are described as 'idiosyncratic' drug induce...